Piroxicam and Cisplatin Treatment Increases Apoptosis in Mesothelioma Cells
Author Information
Author(s): Alfonso Baldi, Maria Teresa Piccolo, Maria Rosaria Boccellino, Aldo Donizetti, Irene Cardillo, Raffaele La Porta, Lucio Quagliuolo, Enrico P. Spugnini, Francesca Cordero, Gennaro Citro, Massimo Menegozzo, Raffaele A. Calogero, Stefania Crispi
Primary Institution: Department of Biochemistry, Section of Pathology, Second University of Naples, Naples, Italy
Hypothesis
The combined treatment of piroxicam and cisplatin increases apoptosis in malignant mesothelioma cells through the mediation of p21.
Conclusion
The study found that the combination of piroxicam and cisplatin significantly increases apoptosis in mesothelioma cells, which is dependent on the expression of p21.
Supporting Evidence
- Piroxicam/cisplatin treatment led to a 33% increase in apoptosis in mesothelioma cells after 24 hours.
- The apoptotic increase was abolished upon silencing of p21, indicating its crucial role.
- Genome-wide analyses identified 536 differentially expressed genes associated with apoptosis following treatment.
Takeaway
This study shows that using two drugs together can help kill cancer cells better than using just one, and it works by affecting a specific protein called p21.
Methodology
The study analyzed the effects of piroxicam and cisplatin on mesothelioma cell lines using genome-wide transcriptional profiling and flow cytometry to assess apoptosis.
Limitations
The study primarily focused on specific cell lines and may not fully represent the complexity of mesothelioma in patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website